The Gross cell surface antigen (GCSA) is produced by cells that are either exogenously infected with murine leukemia virus (MuLV) or are expressing endogenous MuLV genomes. In immune precipitation assays, GCSA was resolved into two serologically distinct 85,000-and 95,000-dalton viral proteins. These antigenic components are glycosylated forms of the polyprotein precursors of the MuLV internal structural proteins.
Virus-induced murine leukemias can be classified into two groups on the basis of virusassociated cell surface antigens that are detected in the complement-dependent cytotoxicity test (14, 15) . The Gross cell surface antigen (GCSA) (15) is produced by cells infected with Gross murine leukemia virus (MuLV), whereas the FMR cell surface antigen (14) is produced by cells infected with the Friend, Moloney, or Rauscher MuLV. GCSA is generally associated with the expression of endogenous MuLV, whereas the FMR antigen is associated with infection by exogenous MuLV.
Antiserum against GCSA is prepared by immunization of C57BL/6 mice with the transplanted AKR spontaneous leukemia K36 (15) . Although the C57BL/6 anti-AKR K36 serum is produced by allogeneic immunization, it is cytotoxic for histocompatible C57BL/6 leukemias (e.g., C57BL/6 leukemia EdG2) that are induced by Gross passage A virus. Tissues from mice of diverse genetic backgrounds can be examined for their GCSA phenotype by absorption of the typing antiserum, with subsequent tests for residual antibody activity against the C57BL/6 EdG2 leukemia. In such tests, antibody to GCSA is absorbed by leukemias induced by Gross virus (15) , by embryo fibroblast cell lines infected with MuLV (13) , and by the normal lymphoid tissues of mice of high leukemic strains (AKR, C58, and PL) (15) . In contrast, antibody to GCSA is not absorbed by the normal lymphoid tissues of mice of low leukemic strains (C57BL/6, BALB/c, and 129) (15) or by virus-free embryo fibroblast cell lines (13) . GCSA also is found in certain leukemias and tumors of mice of low leukemic strains (3, 15) , although in these instances, the occurrence of GCSA is correlated with the activation of endogenous MuLV in these tumor cells (3) .
Studies with rat antisera (5) indicate that GCSA is antigenically complex, possibly representing as many as three serologically distinct antigens.
In immune electron microscopy, the typing antiserum for GCSA does not stain regions of the C57BL/6 Ed G2 cell surface that are associated with budding virions (1) . As a result, it has been suggested that GCSA, although virus associated, is not a structural component of the surface of the virion.
In the studies presented here, we describe (by immune precipitation methods) the immunochemical identification of the GCSA complex. The major components of this complex are two glycosylated precursors (10, 19 ) ofthe viral core proteins, which contain antigenic determinants of the MuLV proteins p30, p12, and plO. In addition, some pools of GCSA antiserum contain antibodies against the viral envelope proteins gp7O and p15(E). These findings are in accord with our previous observations (12) that the typing antiserum for GCSA contains antibodies against the viral structural proteins p30, gp70, and p15(E).
( VOL. 23, 1977 undiluted antiglobulin (Rabbit anti-goat 7S immunoglobulin or goat anti-mouse 7S immunoglobulin, Cappel Laboratories) was added to precipitate the immune complexes. After an additional 2-h incubation on ice, the precipitates were collected by centrifugation (1,000 x g for 20 min) through a cushion of 5% sucrose (in PBS) containing 3% NP-40, followed by three additional washes in PBS with 0.5% NP-40. Centrifugation over the sucrose cushion was particularly effective in minimizing the nonspecific sticking of radiolabeled proteins to the immune precipitates. In some experiments, the antigen-antibody complexes formed from the incubation of antiserum with the radiolabeled membrane preparation were precipitated by the addition of 3 mg of Staphylococcus aureus with a 30-min incubation on ice (8 SDS-polyacrylamide gel electrophoresis (PAGE).
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PAGE was performed according to Laemmli (11) in cylindrical gels (12 cm in length) or in 1.5-mm slab gels; cylindrical gels were subjected to electrophoresis at 0.55 mA per tube for 17 h, whereas slab gels were subjected to electrophoresis at 100 V for 7 h. PAGE of viral proteins was performed in 12.5% gels. PAGE of cellular extracts was performed in 7.5% gels. Samples containing '251-labeled proteins were subjected to coelectrophoresis in cylindrical gels with '31I-labeled protein markers (phosphorylase a, 94,000 daltons; bovine serum albumin, 68,000 daltons; and the heavy chain of rabbit immunoglobulin, 50,000 daltons). Samples containing 3H-labeled MuLV proteins were subjected to coelectrophoresis with '4C-labeled MuLV as a marker.
RESULTS To determine the relationship of GCSA to MuLV-coded proteins we utilized two experimental approaches: (i) analysis of the GCSA typing serum (C57BL/6 anti-AKR K36) for antibodies against MuLV proteins, and (ii) analysis of the GCSA typing cell (C57BL/6 EdG2) for the expression of MuLV proteins on the cell surface.
Precipitation of intact MuLV by GCSA typing serum. RIP assays of intact 1 3H]leucinelabeled AKR MuLV with a variety of antiviral sera are shown in Fig. 1 .
Goat antiserum prepared against the viral envelope protein gp7O precipitated, to high titer, 3H-labeled AKR MuLV, whereas goat antisera prepared against the internal viral proteins p30, p15, p12, and plO had only minimal activity (Fig. lA) .
The GCSA typing serum, C57BL/6 anti-AKR K36, precipitated to high titer the 3H-labeled (Fig. 1B) . In contrast, the sera of normal nonimmunized C57BL/6 mice did not react with the virus (Fig. 1B) .
Normal sera from mice of the I strain also precipitated 3H-labeled AKR MuLV (Fig. 1B) . This finding confirms our previous observations (11) that mice of the I strain naturally produce antibodies to their endogenous MuLV.
Precipitation of viral proteins by GCSA typing serum. To determine the protein of the virus to which antibodies in the C57BL/6 anti-AKR K36 serum were directed, the RIP test was performed with detergent-disrupted 3H-labeled AKR MuLV, and the immune precipitate was examined by PAGE in the presence of SDS.
PAGE of a control preparation of AKR MuLV is shown in Fig. 2A . Eight major viral polypeptides exist in the virion: these are designated gp7O, gp45, p30, p17, p15(E), p15, p12, and plO, according to the nomenclature for proteins of the oncornaviruses (2) . PAGE of immune precipitates formed between the C57BL/6 anti-AKR K36 serum and the proteins of NP-40-disrupted AKR MuLV (Fig. 2B) demonstrated that the antiviral antibodies present in this serum were directed primarily against the viral proteins p30 and p15(E); however, minor reactions were also observed with gp7O, p17, and p15. PAGE of immune precipitates formed between normal sera of C57BL/6 mice and the proteins of NP-40-disrupted AKR MuLV failed to show significant antiviral antibodies in these mice (Fig. 2C) .
PAGE of an immune precipitate formed between the normal serum of an I strain mouse with the proteins of NP-40-disrupted AKR MuLV (Fig. 2D ) demonstrated antiviral antibodies that were directed primarily against the viral protein p15(E). Analysis of other sera from normal I mice revealed a similar reaction with p15(E), although in some cases these sera also showed an additional reaction with gp7O (11) .
The spectrum of anti-MuLV antibodies [precipitating gp7O and p15(E) proteins] in the sera of normal I mice is qualitatively similar to the antiviral antibodies that have been observed in the sera of mice of other inbred strains that develop a natural immune response to MuLV (7, 11) . In contrast, antibodies to p30 protein, as observed in the C57BL/6 anti-AKR K36 serum, have not been observed in the sera of normal or immunized mice of a wide variety of genetic backgrounds (7, 11, 12) .
Cytotoxic tests with C57BL/6 Ed G2 cells. Cytotoxic assays of 5tCr-labeled C57BL/6 Ed G2 cells with a variety of antiviral sera are shown in Fig. 3 .
Goat antisera prepared against the viral pro-teins gp7O, p30, p12, and plO were strongly cytotoxic for the C57BL/6 Ed G2 cells (Fig. 3A ). An antiserum prepared against the p15 protein also was cytotoxic for C57BL/6 Ed G2 but to a lower titer. In parallel tests, goat antisera to the viral proteins p30, p15, p12, and plO were not demonstrably cytotoxic for normal C57BL/6 spleen cells. Antiserum prepared against gp7O was weakly cytotoxic (titer, <1/50) for normal C57BL/6 spleen cells; however, this may reflect the low level of gp7O that is known to occur (18) in normal lymphoid tissues of C57BL/6 mice.
The GCSA typing serum, C57BL/6 anti-AKR K36, was strongly cytotoxic for the C57BL/6 Ed G2 cells (Fig. 3B) . Sera from normal nonimmunized C57BL/6 mice were not cytotoxic for the C57BL/6 Ed G2 cells (Fig. 3B) . Sera from normal I strain mice, although containing higher titers of anti-pl5(E) antibody, exhibited minimal cytotoxicity towards the C57BL/6 EdG2 cells (Fig. 3B) . In parallel tests, the GCSA typing serum and normal sera of I strain mice were not cytotoxic for normal C57BL/6 spleen cells.
Precipitation of MuLV antigens from the cell surface of C57BL/6 EdG2 cells. To identify the MuLV proteins on the surface of C57BL/6 Ed G2 cells to which antibodies in the C57BL/6 anti-AKR K36 serum were directed, the RIP test was performed with detergentdisrupted '2''I-labeled C57BL/6 Ed G2 membranes, and the immune precipitates were examined by PAGE in the presence of SDS.
PAGE of immune precipitates formed between goat antisera prepared against viral proteins and '2.'I-labeled membrane extracts of C57BL/6 Ed G2 cells is shown in Fig. 4 . Three serologically distinct reactions were observed. (i) Anti-gp7O serum precipitated a single 70,000-dalton protein.
(ii) Anti-p30 and anti-p12 sera precipitated two high-molecular-weight (85,000 and 95,000) proteins. We (10) and others (19) have previously demonstrated that these proteins are the glycosylated polyprotein precursors of the internal structural proteins (p30, p15, p12, and plO) of MuLV. (iii) Anti-plO serum precipitated the higher-molecular-weight (95,000) polyprotein, but did not react with the lower-molecular-weight (85,000) polyprotein.
PAGE of immune precipitates formed between the GCSA typing serum and '12.I-labeled membrane extracts of C57BL/6 Ed G2 cells are also shown in Fig. 4 . This antiserum precipitated three proteins of molecular weights 70,000, 85,000, and 95,000, corresponding in size to the viral envelope protein gp7O and the viral polyprotein precursors that were precipitated by the goat antisera. PAGE of immune precipitates formed between I normal sera and 12.51I_ labeled membrane extracts of C57BL/6 Ed G2 demonstrated reactions with a single 70,000-dalton protein. The failure to detect reactions of I normal sera with p15(E) protein on the cell surface was most likely due to the fact that p15(E) is not accessible on the cell surface (or in virions) to iodination by the ''25I-lactoperoxidase method (unpublished data).
Serological identification of GCSA as the glycosylated polyproteins of MuLV. The precipitation of two proteins of 85,000 and 95,000 daltons from the membrane extract of C57BL/6 EdG2 cells by GCSA typing serum suggested that GCSA may represent antigenic determinants on the glycosylated polyproteins of MuLV. To definitively demonstrate the presence of p30 antigenic sites on GCSA, we used immunoadsorbant columns to remove selected antigenic specificities from the C57BL/6 EdG2 extracts.
Immunoadsorbant columns were prepared by the covalent linkage of goat anti-p30 serum to cyanogen bromide-activated Sepharose 4B. Cell membrane preparations were chromatographed through these columns and then examined for residual activity with antisera. Proteins bound to the immunoadsorbant columns were eluted by thiocyanate and examined by immune precipitation for virus-related antigens. The results of these studies with a cell extract from C57BL/6 Ed G2 are shown in Fig. 
5.
Before passage through the anti-p30 immunoadsorbant, the C57BL/6 Ed G2 cell extract contained 85,000-and 95,000-dalton antigens that reacted with the anti-p30 serum, and a 70,000-dalton antigen that reacted with the anti-gp7O serum. The GCSA typing serum reacted with 70,000-, 85,000-, and 95,000-dalton species (Fig. 5) immunoadsorbant, the cell extract no longer contained the 85,000-and 95,000-dalton antigens that were immunologically reactive with both the anti-p30 and GCSA typing serum. However, the 70,000-dalton antigen that was reactive with the anti-gp7O and the GCSA typing serum was still present. Elution of the adsorbed proteins with thiocyanate yielded the 85,000-and 95,000-dalton proteins that were immunologically reactive with both the antip30 and GCSA typing serum. Therefore, we have concluded that GCSA and p30 protein share common antigenic determinants.
In a comparison (Table 1) of several pools of C57BL/6 anti-AKR K36 sera, it was found that the cytotoxicity of these sera for the C57BL/6 EdG2 cell was correlated with their reactions with the 85,000-and 95,000-dalton cell surface antigens. The cytotoxic activity of these antisera was unrelated to their reactions with the 70,000-dalton cell surface antigen. DISCUSSION The studies presented here demonstrate that GCSA is a complex composed of several MuLVcoded proteins. The major components of GCSA are the 85,000-and 95,000-dalton glycosylated polyproteins that contain antigenic determinants of the viral internal structural proteins. This is demonstrated by the following: (i) the GCSA typing serum predominantly precipitates 85,000-and 95,000-dalton proteins from 1251-labeled C57BL/6 Ed G2 membrane preparations, (ii) the 85,000-and 95,000-dalton proteins that react with the GCSA typing serum can be selectively removed from the C57BL/6 EdG2 extract by an anti-p30 immunoadsorbant, and (iii) the cytotoxic activity of GCSA antisera is correlated with the reaction of these sera with the 85,000-and 95,000-dalton proteins.
These findings are in agreement with those of Snyder et al. (16) , who independently demonstrated that the major component of the GCSA reaction is the glycosylated polyprotein precursor to the MuLV internal structural proteins. In addition to using immune precipitation methods, their studies also included the demonstration that the We have also found that antibodies against the gp7O and p15(E) viral proteins are present in some pools of GCSA typing antisera. These GCSA antisera precipitate (i) intact MuLV, (ii) gp7O and p15(E) proteins from detergent-disrupted MuLV, and (iii) a 70,000-dalton protein from the cell surface of C57BL/6 EdG2. However, it should be stressed that the presence of antibody to gp70 and p15(E) in GCSA typing serum varies considerably from one pool of serum to another. In a comparison of several pools of C57BL/6 anti-AKR K36 serum (Table  1) , we observed that the cytotoxic titer of these sera for C57BL/6 EdG2 was closely related to the precipitation titer of these sera for the 85,000-and 95,000-dalton polyproteins. Furthermore, we have found that normal sera of I strain mice, which contain high titers of antibody against p15(E), were only minimally cytotoxic for C57BL/6 Ed G2. The immune response of mice to the glycosylated polyprotein appears to be restricted to animals that have been immunized with leukemia cells. In previous studies (12) we examined a panel of sera from C57BL/6 mice that were immunized with a variety of cellular antigens for antibodies against MuLV. With the exception of the GCSA typing serum, these sera either (i) failed to contain demonstrable antiviral antibodies, or (ii) contained antibodies exclusively against the MuLV proteins p15(E) and gp70. The presence of high titers of anti-p30 antibody in the GCSA typing sera led us to hypothesize that the AKR K36 cells contained on their surface a unique configuration of the p30 antigenic determinants. From the studies described here, we now attribute the anti-p30 antibodies in the GCSA typing serum to immunization by the glycosylated polyproteins of MuLV that occur as integral components of the cell surface of the AKR K36 cell. Recently, Stephenson et al. (17) demonstrated by radioimmunoassay that mice of low leukemic strains can be immunized with purified preparations of p30 protein. However, it appears that the titers of anti-p30 antibodies induced by purified p30 protein are significantly lower than those obtained by immunization with cells that contain the glycosylated polyproteins as surface antigens.
The identification of GCSA as a complex of glycosylated virus-coded proteins that are expressed on the cell surface may relate to the observations of Knight et al. (9) , who found that purified p30 protein blocked the killing of MuLV-infected leukemia cells by cytotoxic lymphocytes. The isolation of GCSA (by the combined use of lectin and immunoadsorbant affinity chromatography) will allow us to determine the role of these antigens in cell-mediated immunity to leukemia.
